Literature DB >> 8133732

Peliosis hepatis in a young adult bodybuilder.

A Cabasso1.   

Abstract

Peliosis hepatis, an unusual condition characterized by blood-filled spaces within the hepatic parenchyma, usually occurs in a variety of chronic wasting diseases such as tuberculosis or malignancy. It has been described in patients undergoing therapy with anabolic steroids in pharmacologic doses over extended periods of time. To our knowledge it has not been described in athletes who utilize them for performance enhancement. This report concerns a 27-yr-old bodybuilder with peliosis hepatis, which developed after chronic intermittent use of anabolic steroids.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8133732

Source DB:  PubMed          Journal:  Med Sci Sports Exerc        ISSN: 0195-9131            Impact factor:   5.411


  7 in total

Review 1.  Chemistry and structural biology of androgen receptor.

Authors:  Wenqing Gao; Casey E Bohl; James T Dalton
Journal:  Chem Rev       Date:  2005-09       Impact factor: 60.622

Review 2.  Medical issues associated with anabolic steroid use: are they exaggerated?

Authors:  Jay R Hoffman; Nicholas A Ratamess
Journal:  J Sports Sci Med       Date:  2006-06-01       Impact factor: 2.988

Review 3.  Behavioural manifestations of anabolic steroid use.

Authors:  Adam J Trenton; Glenn W Currier
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

Review 4.  Effects of androgenic-anabolic steroids in athletes.

Authors:  Fred Hartgens; Harm Kuipers
Journal:  Sports Med       Date:  2004       Impact factor: 11.136

5.  Anabolic steroid-induced cardiomyopathy underlying acute liver failure in a young bodybuilder.

Authors:  Miguel Bispo; Ana Valente; Rosário Maldonado; Rui Palma; Helena Glória; João Nóbrega; Paula Alexandrino
Journal:  World J Gastroenterol       Date:  2009-06-21       Impact factor: 5.742

Review 6.  The anabolic androgenic steroid oxandrolone in the treatment of wasting and catabolic disorders: review of efficacy and safety.

Authors:  Rhonda Orr; Maria Fiatarone Singh
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 7.  Scientific and Regulatory Perspectives in Herbal and Dietary Supplement Associated Hepatotoxicity in the United States.

Authors:  Mark I Avigan; Robert P Mozersky; Leonard B Seeff
Journal:  Int J Mol Sci       Date:  2016-03-03       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.